Literature DB >> 21412942

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

Eugénie Mutez1, Frédéric Leprêtre, Emilie Le Rhun, Lydie Larvor, Aurélie Duflot, Vincent Mouroux, Jean-Pierre Kerckaert, Martin Figeac, Kathy Dujardin, Alain Destée, Marie-Christine Chartier-Harlin.   

Abstract

Genomic multiplication of the alpha-synuclein gene (SNCA) locus is one cause of familial Parkinson disease (PD). We performed detailed genomic, SNCA expression level, clinical, neuropsychological and functional imaging analyses of a parkinsonian kindred with a known duplication of the SNCA locus. We demonstrated that the duplication spanned 4.928 Mb (encompassing 31 known and putative genes) and was the largest to have been described at this locus. The presence of several repetitive long interspersed nuclear elements (LINEs) flanking the potential break area suggested that the duplication resulted from a genomic recombination between LINEs. We sequenced the break junction and confirmed the involvement of L1PA2 and L1PA4 in a non-allelic, homologous recombination. An analysis of mRNA levels in immortalized lymphoblastoid cells and peripheral blood mononuclear cells showed SNCA overexpression in subjects with the duplication, as well as overexpression of 13 other genes highlighting the usefulness of such cell models to study this duplication. Interestingly, abnormal tracer uptake in DaTSCAN(®) imaging correlated with the severity of the clinical symptoms. Our detailed genomic analysis and clinical exploration enabled us to specify the genotype-phenotype relationship, identify a case of presymptomatic PD and gain insight into the role of LINEs in SNCA locus duplication.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412942     DOI: 10.1002/humu.21459

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

Review 1.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

2.  Increased expression of α-synuclein by SNCA duplication is associated with resistance to toxic stimuli.

Authors:  Han-Joon Kim; Beom S Jeon; Min-Yung Yoon; Sung-Sup Park; Kwang-Woo Lee
Journal:  J Mol Neurosci       Date:  2012-03-06       Impact factor: 3.444

Review 3.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

Review 4.  A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.

Authors:  Nicola Tambasco; Pasquale Nigro; Michele Romoli; Paolo Prontera; Simone Simoni; Paolo Calabresi
Journal:  J Neural Transm (Vienna)       Date:  2016-06-01       Impact factor: 3.575

5.  Replication-Based Rearrangements Are a Common Mechanism for SNCA Duplication in Parkinson's Disease.

Authors:  Soo Hyun Seo; Albino Bacolla; Dallah Yoo; Yoon Jung Koo; Sung Im Cho; Man Jin Kim; Moon-Woo Seong; Han-Joon Kim; Jong-Min Kim; John A Tainer; Sung Sup Park; Ji Yeon Kim; Beomseok Jeon
Journal:  Mov Disord       Date:  2020-02-10       Impact factor: 10.338

6.  α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Authors:  Beate Ritz; Shannon L Rhodes; Yvette Bordelon; Jeff Bronstein
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 7.  Modulating the Amyloidogenesis of α-Synuclein.

Authors:  Kalkena Sivanesam; Niels H Andersen
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 8.  Advances with microRNAs in Parkinson's disease research.

Authors:  Liuqing Ma; Liangming Wei; Fei Wu; Zhenhua Hu; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-10-01       Impact factor: 4.162

9.  Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.

Authors:  Christos Proukakis; Henry Houlden; Anthony H Schapira
Journal:  Mov Disord       Date:  2013-05-14       Impact factor: 10.338

10.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.